News

The parents of a healthy 5-month-old boy bring him to the office for evaluation of an enlarging yellowish nodule on the back of his right thigh. It started as a pink macule several months ago and became yellow and lumpy over the last month. The infant was born at term and has grown and developed normally. His parents deny any trauma, but report occasional bleeding from the surface of the nodule. They deny any new medications or outdoor exposures. There is no history of new topical skin products.

A therapy dog program at a children’s hospital provides comfort for pediatric patients and families facing the unfamiliar and a sense of normalcy that makes a frightening hospital experience less so.

We’ve been asking the same basic questions in our Annual Issues and Attitudes Survey for the past 4 years and listening to your answers so that we can discern any trends in your thinking and professional behaviors. The jury is in on 2017, so here are some of the key findings. No P values here, but lots of anecdotal comments. And still some interesting feedback on what you’re confronting and juggling from patients, parents, and payments.

Dr. Bass’ recent article in Contemporary Pediatrics, “Personalized medicine, right drug, right patient, right time,” provides a miniature but profound view of what may be the future of pediatric healthcare: focusing on healthcare that is truly individualized through precision science in the areas of diagnosis and treatment, rather than generalized, population-based treatment guidelines.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a large retrospective cohort study published in the Journal of the American Academy of Dermatology that examined whether children with pediatric psoriasis are at increased risk of cancer and discusses 2 caveats to the findings.